Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 275-277

  Sriskandan, Shiranee ^a   McKee, Andrew ^a   Hall, Lisa ^a   Cohen, Jonathan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; EXOTOXIN; SUPERANTIGEN;

ARTICLE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; STREPTOCOCCUS PYOGENES; SUPERNATANT; TOXIC SHOCK SYNDROME;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CLINDAMYCIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOTOXINS; MEMBRANE PROTEINS; PENICILLINS; PYROGENS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS;

EID: 0030798267     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.275     Document Type: Article

References (10)

1. Schlievert, P. M., Assimacopoulos, A. P. & Cleary, P. P. (1996). Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. Journal of Laboratory and Clinical Medicine 127, 13-22.
2. Stevens, D. L., Bryant, A. E. & Yan, S. (1994). Invasive group A streptococcal infection: new concepts in antibiotic treatment. International Journal of Antimicrobial Agents 4, 297-301.
3. Sriskandan, S., Moyes, D., Buttery, L. K., Krausz, T., Evans, T. J., Polak, J. et al. (1996). Streptococcal pyrogenic exotoxin A release, distribution and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes. Journal of Infectious Diseases 173, 1399-407.
4. Sriskandan, S., Evans, T. J. & Cohen, J. (1996). Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma. Journal of Immunology 156, 2430-5.
5. Stevens, D. L., Bryant, A. E. & Hackett, S. P. (1995). Antibiotic effects on bacterial viability, toxin production, and host response. Clinical Infectious Diseases 20, Suppl. 2, S154-7.
6. Schlievert, P. M. & Kelly, J. A. (1984). Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. Journal of Infectious Diseases 149, 471.
7. Stevens, D. L., Gibbons, A. E., Bergstrom, R. & Winn, V. (1988). The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. Journal of Infectious Diseases 158, 23-8.
8. Shibl, A. M. & Al-Sowaygh, I. A. (1979). Differential inhibition of bacterial growth and hemolysin production by lincosamide antibiotics. Journal of Bacteriology 137, 1022-3.
9. Gemmell, C. G., Peterson, P. K., Schmeling, D., Kim, Y., Mathews, J., Wannamaker, L. et al. (1981). Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. Journal of Clinical Investigation 67, 1249-56.
10. Brook, I., Gober, A. E. & Leyva, F. (1995). In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule. Antimicrobial Agents and Chemotherapy 39, 1565-8.